FDA Inspection 1252580 — Jeffrey T. Apter, M.D.

Jeffrey T. Apter, M.D. — FEI 3016544902

The FDA completed an inspection of Jeffrey T. Apter, M.D. on Oct 22, 2024 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 22, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.